Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T23:48:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces changes to NIH websites and explains that some agency content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T23:10:58.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T23:30:25.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T23:38:55.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The study record history page appears unchanged, with its version list and study update categories intact.
    Difference
    0.1%
    Check dated 2026-10-04T23:19:11.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    A newer site revision (v3.7.0) was added to the history. The older revision (v3.6.6) was removed.
    Difference
    0.1%
    Check dated 2026-09-20T22:53:06.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.